Photoirradiation (λ > 300 nm) of Degussa (Evonik) P25 TiO2, a mixture of anatase and rutile particles, in alcohols containing nitroaromatics at room temperature produces the corresponding imines with very high yields (80-96%). Other commercially available anatase or rutile TiO2 particles, however, exhibit very low yields (<30%). The imine formation involves two step reactions on the TiO2 surface: (i) photocatalytic oxidation of alcohols (aldehyde formation) and reduction of nitrobenzene (aniline formation) and (ii) condensation of the formed aldehyde and aniline on the Lewis acid sites (imine formation). The respective anatase and rutile particles were isolated from P25 TiO2 by the H2O2/NH3 and HF treatments to clarify the activity of these two step reactions. Photocatalysis experiments revealed that the active sites for photocatalytic reactions on P25 TiO2 are the rutile particles, promoting efficient reduction of nitrobenzene on the surface defects. In contrast, catalysis experiments showed that the anatase particles isolated from P25 TiO2 exhibit very high activity for condensation of aldehyde and aniline, because the number of Lewis acid sites on the particles (73 μmol g(-1)) is much higher than that of other commercially available anatase or rutile particles (<15 μmol g(-1)). The P25 TiO2 particles therefore successfully promote tandem photocatalytic and catalytic reactions on the respective rutile and anatase particles, thus producing imines with very high yields.

Previously, we reported that mRNA expression of ficolin-1 (FCN1), a component of the complement lectin pathway, is elevated in peripheral blood mononuclear cells of patients with vasculitis syndrome, and that FCN1-positive cells infiltrate into inflamed regions in patient specimens. In addition, we reported that serum FCN1 concentration is elevated in patients with Kawasaki disease (KD), a pediatric vasculitis, but dramatically decreases after intravenous immunoglobulin (IVIG) treatment. Furthermore, we showed that FCN1 binds to IgG1 in a pull-down assay. These results suggested that removal of FCN1 may be a therapeutic mechanism of IVIG. In this study, we prepared anti-FCN1 monoclonal antibody (mAb) and examined its therapeutic potential in mice treated with Candida albicans water-soluble fraction (CAWS), which induces KD-like vasculitis in the coronary artery. Indeed, treatment with anti-FCN1 mAb decreased the histological score of vasculitis (p = 0.03). To investigate the role of FCN1, we assessed blood samples of patients with various autoimmune diseases and demonstrated that serum levels of FCN1 were elevated not only in patients with vasculitis, but also in those with rheumatoid arthritis. Additionally, FCN1-targeted treatment of a mouse model of arthritis (CAIA), revealed that administration of anti-FCN1 mAb ameliorated symptoms of arthritis (p< 0.01). These results suggest that FCN1 is involved in the pathogenesis of autoimmune diseases, and that targeting FCN1 represents a promising strategy for treating these diseases.

Visible-light irradiation (λ < 600 nm) of commercially-available CdS in alcohol successfully promotes hydrogenation of azobenzene to hydrazobenzene with more than 95% selectivity. This is promoted by strong adsorption of azobenzene to the photoformed zerovalent Cd species adjacent to the surface S vacancies on CdS; this leads to efficient reduction to hydrazobenzene.